{
 "PrintNo":"S927","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-01-09T10:42:35.87104Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2023-01-09","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[
  {"ID":914,"Name":"Roxanne J. Persaud","Short":"PERSAUD"},
  {"ID":438,"Name":"Brad Hoylman-Sigal","Short":"HOYLMAN-SIGAL"},{"ID":401,"Name":"Liz Krueger","Short":"KRUEGER"}
 ],
 "Title":"Requires health insurance policies to cover comprehensive genetic screening for ovarian and prostate cancers",
 "Summary":"Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to requiring health insurance policies to fully cover comprehensive genetic testing and FDA approved biomarker testing for ovarian and prostate cancers",
 "SameAsPrintNo":"A9075-2023",
 "PreviousVersions":["A3761-2013","A8472-2013","A291-2015","A1807-2017","S4768-2019","S105-2021"]
}